Preoperative use of enoxaparin increases the risk of postoperative bleeding and re-exploration in cardiac surgery patients.
McDonald SB, Renna M, Spitznagel EL, et al.
J Cardiothorac Vasc Anesth 2005;19(1):4-10.
Review by M. Levi
Recombinant activated factor VII (NovoSeven): addition to replacement therapy in acute, uncontrolled and life-threatening bleeding.
Mayo A, Misgav M, Kluger Y, et al.
Vox Sang 2004;87:34-40.
Review by
Antidotes to haemorrhage: recombinant factor VIIa.
Kessler CM
Best Pract Res Clin Haematol 2004;17:183-197.
Review by M. Aldouri
The effects of a polymerized bovine-derived hemoglobin solution in a rabbit model of arterial thrombosis and bleeding.
Marret E, Bonnin P, Mazoyer E, Riou B, Jacobs T, Coriat P, Samama CM
Anesth Analg 2004;98(3):604-610.
Review by P. Van der Linden, J.-F. Hardy
An assessment of the management of acute bleeding varices: a multicenter prospective member-based study.
Sorbi D, Gostout CJ, Peura D, et al.
Am J Gastroenterol 2003;98(11):2424-2434.
Review by
Improved hemostasis with superactive analogs of factor VIIa in a mouse model of hemophilia A.
Tranholm M, Kristensen K, Kristensen AT, Pyke C, Rojkjaer R, Persson E
Blood 2003;102(10):3615-3620.
Review by
Increased local procoagulant action: a mechanism contributing to the favorable hemostatic effect of recombinant FVIIa in PLT disorders.
Galan AM, Tonda R, Pino M, Reverter JC, Ordinas A, Escolar G
Transfusion 2003;43(7):885-892.
Review by
The use of recombinant factor VIIa in children with inherited platelet function disorders.
Almeida AM, Khair K, Hann I, Liesner R
Br J Haematol 2003;121(3):477-481.
Review by Aldouri M
Effect of recombinant activated factor VII on perioperative blood loss in patients undergoing retropubic prostatectomy: a double-blind placebo-controlled randomised trial.
Friederich PW, Henny CP, Messelink EJ, et al.
Lancet 2003;361(9353):201-205.
Review by
Treatment of critical bleeding in the future intensive care unit. [Editorial]
Goodnough LT
Intensive Care Med 2002;28(Suppl 2):S221.
Review by Aldouri M
Recombinant factor VIIa after aortic valve replacement in a patient with osteogenesis imperfecta.
Kastrup M, von Heymann C, Hotz H, et al.
Ann Thorac Surg 2002;74(3):910-912.
Review by
Case report on recombinant coagulation factor VIIa in the treatment of three haemophilia A patients with inhibitors in Singapore.
Ng HJ, Lee LH
Ann Acad Med Singapore 2002;31(2):241-244.
Review by Aldouri M
Influence of a new hydroxyethylstarch preparation (HES 130/ 0.4) on coagulation in cardiac surgical patients.
Haisch G, Boldt J, Krebs C, Suttner S, Lehmann A, Isgro F
J Cardiothorac Vasc Anesth 2001;15(3):316-321.
Review by Monty Mythen
NATA: Network for the Advancement of Patient Blood Management, Haemostasis and Thrombosis
MISSION: Providing a multidisciplinary forum for dialogue between haematologists, transfusion medicine specialists, anaesthesiologists, intensive care and emergency physicians, surgeons, perfusionists, nurses, biomedical scientists and other healthcare professionals.
Sitemap
Contact us
- secretary@nataonline.com
-
NATA
Rue de l’Industrie 24
1040 Bruxelles - VAT: 0781668659